“We have seen great demand for clinical supply services in China. This expansion will increase both capacity and capabilities at the Shanghai facility, and makes provision for the growing trend in clinical trials of advanced therapeutics requiring specialized storage and handling capabilities, including deep-frozen for emerging biotech companies,” said Roel de Nobel, vice president and general manager, APAC, clinical supply services.

The facility in the Waigaoqiao Free Trade Zone is one of two clinical supply sites that Catalent operates in Shanghai – the other, which opened in April 2019, is located in Tangzhen. Together, said Catalent, they provide sponsors with optimized supply solutions for studies performed both in China and Asia-Pacific, as well as worldwide.

Author: Elaine Burridge, Freelance Journalist